These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7136218)
1. [Prevention and drug therapy of liver diseases]. Weizel A ZFA (Stuttgart); 1982 Aug; 58(24):1270-4. PubMed ID: 7136218 [No Abstract] [Full Text] [Related]
2. [Therapy of liver diseases, possibilities and problems]. Renger F Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):9-13. PubMed ID: 4100481 [No Abstract] [Full Text] [Related]
3. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)]. Magnenat P Ther Umsch; 1979 May; 36(5):432-8. PubMed ID: 451956 [No Abstract] [Full Text] [Related]
4. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process]. Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352 [No Abstract] [Full Text] [Related]
5. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver]. Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757 [TBL] [Abstract][Full Text] [Related]
6. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. 3. Evolution of the immunologic picture. IV. Improvement of the functional parameters]. Nicolescu T; Bittman E; Stoiculescu P; Bordeianu A; Boroş I; Jinga V; Moucha R; Ciontescu L Med Interna (Bucur); 1974 Apr; 26(4):465-78. PubMed ID: 4839353 [No Abstract] [Full Text] [Related]
7. [Glucocorticoids and immunosuppressive agents in liver diseases]. Arpa Gutierrez FJ; Silva Pozo J Rev Esp Enferm Apar Dig; 1970 Dec; 32(7):763-82. PubMed ID: 4926636 [No Abstract] [Full Text] [Related]
8. [For which liver diseases is immunosuppressive therapy indicated?]. Bannaski H Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889 [TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive therapy in active chronic hepatopathies]. Buligescu L; Ciontea M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(3):241-56. PubMed ID: 30138 [No Abstract] [Full Text] [Related]
14. [Long-term therapy of liver diseases]. Renger F; Dökert B Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:165-8. PubMed ID: 4728085 [No Abstract] [Full Text] [Related]
15. [Immunodepressants in chronic liver diseases (a review of the literature and the authors' own data)]. Podymova SD; Nasonov EL Ter Arkh; 1976; 48(3):40-8. PubMed ID: 795076 [No Abstract] [Full Text] [Related]
16. [Immunosuppressive therapy of chronic hepatitis]. Meyer zum Büschenfelde Dtsch Med J; 1969 Aug; 20(16):522-7. PubMed ID: 5344061 [No Abstract] [Full Text] [Related]
17. [Long-term therapy of liver diseases]. Markoff N Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921 [No Abstract] [Full Text] [Related]
18. [Immunological changes during the treatment of chronic liver diseases with immunosuppressive agents]. Zivković R; Babić D; Radosević V; Sket-Janković N; Bogdan I; Vercko K; Varlaj V Acta Med Iugosl; 1976; 30(5):497-508. PubMed ID: 1015350 [No Abstract] [Full Text] [Related]
19. Response to steroid and immunosuppressor therapy in patients with chronic active liver disease (CALD) non-related to the presence of hepatitis Bs antigen. Robles G; Centeno F; Uribe M; Guevara L Rev Invest Clin; 1980; 32(3):271-6. PubMed ID: 7444226 [No Abstract] [Full Text] [Related]
20. [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents]. Bauch K; Büttner W; Lewicki I; Zimmermann S; Dempe A Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:169-72. PubMed ID: 4728086 [No Abstract] [Full Text] [Related] [Next] [New Search]